Nasdaq ETFs

In recent trading, shares of PTC Inc (Symbol: PTC) have crossed above the average analyst 12-month target price of $100.43, changing hands for $101.14/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation,

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itsel

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itsel

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itsel

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itsel

In recent trading, shares of Carvana Co (Symbol: CVNA) have crossed above the average analyst 12-month target price of $233.19, changing hands for $234.30/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuati

In recent trading, shares of Medpace Holdings Inc (Symbol: MEDP) have crossed above the average analyst 12-month target price of $125.00, changing hands for $126.43/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade

In recent trading, shares of MercadoLibre Inc (Symbol: MELI) have crossed above the average analyst 12-month target price of $1413.64, changing hands for $1416.99/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on

In recent trading, shares of Scotts Miracle-Gro Co (Symbol: SMG) have crossed above the average analyst 12-month target price of $168.75, changing hands for $169.33/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade

In recent trading, shares of Vipshop Holdings Ltd (Symbol: VIPS) have crossed above the average analyst 12-month target price of $23.53, changing hands for $24.24/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on

In recent trading, shares of Array Technologies Inc (Symbol: ARRY) have crossed above the average analyst 12-month target price of $43.92, changing hands for $45.10/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade

In recent trading, shares of NovoCure Ltd (Symbol: NVCR) have crossed above the average analyst 12-month target price of $128.67, changing hands for $132.36/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valua

By Jeremy Schwartz, CFA, Global Head of Research, WisdomTree Investments Last week’s Behind the Markets podcast featured a discussion with Paul Esposito, senior portfolio manager at Prestige Wealth Management Group and chair of their investment policy committee. Paul is responsible for global capital market research, formulating both strategic and tactical asset allocation recommendations as well as [...] Read more at ETFtrends.com.

By Shaun Wurzbach, Managing Director, Global Head of Financial Advisor Channel, S&P Dow Jones Indices I define core ESG indexing as the use of indices designed to apply environmental, social, and governance (ESG) screening and ESG scores to recognized and sometimes iconic indices like the S&P 500®, S&P/ASX 200, or S&P/TSX Composite. These headline indices become actionable components of asset [...] Read more at ETFtrends.com.

By VanEck Hope Springs Eternal Hopes of a return to normality are increasing after a year of pandemic-induced tumult. News that COVID-19 vaccines developed by Pfizer and BioNTech, and Moderna were more than 90% effective in clinical trials lifted global stock markets, with health care stocks outpacing the gains in the U.S., Asia and Europe [...] Read more at ETFtrends.com.

By Frank Holmes, U.S. Funds America, and the world, received another huge shot of hope this week. Biotech firm Moderna announced today that its coronavirus vaccine is 94.5% effective at preventing COVID-19. This news comes after the $210 billion drugmaker Pfizer said last Monday that its vaccine is 90% effective. Today at the open, travel [...] Read more at ETFtrends.com.

By Frank Holmes, U.S. Funds By now you may have heard that President Donald Trump signed an executive order banning Americans from investing in a select number of Chinese firms that have ties to China’s military. Since we invest heavily in the country and other Asian economies, through our China Region Fund (USCOX), I figured it’d be [...] Read more at ETFtrends.com.

For investors looking for momentum, First Trust Nasdaq Artificial Intelligence and Robotics ETF ROBT is probably a suitable pick. The fund just hit a 52-week high and is up 96.8% from its 52-week low price of $22.51/share.

By Eric Dutram, Contributor, DWS Twice a year, the Federal Reserve puts out an assessment of the “resilience of the U.S. financial system”, highlighting key risks and potential flashpoints that Fed members are watching. While this often focuses on traditional metrics such as valuation, borrowing levels or leverage, the latest edition added a new issue. For [...] Read more at ETFtrends.com.

By Gabor Gurbacs, Director, Digital Assets Strategy; Kyle DaCruz, Product Manager, Active Strategies; Denis Zinoviev, Associate Product Manager, ETFs Historically, bitcoin has been discussed in the news and among investors as a nascent and volatile asset outside of the traditional stock and capital markets. Much of the volatility over the past few years can be attributed to sensitivity to small [...] Read more at ETFtrends.com.